Getting to the Point: LAI Learning Module

Course Introduction

Bridging the Reaction Gap

Transitioning to Long-Acting Injectables early in schizophrenia treatment to prevent relapse and improve patient outcomes.

task_alt Learning Objectives

1

Describe proactive guideline recommendations for early LAI administration and review evidence from clinical trials.
2

Demonstrate shared decision-making techniques to align treatment with patient goals and autonomy.
3

Master clinic logistics and transition protocols, including proper injection techniques for Ventrogluteal and gluteal sites.

warning

The Problem

Despite clear evidence of superior outcomes, only 4% of patients receive LAIs early in treatment.

Module Overview

timer Total Duration

60 Minutes

workspace_premium Certification

1.0 AMA PRA / CE

Section 1

Proactive Treatment & Guidelines

psychology The Evidence Gap

Why Early Initiation?

Schizophrenia leads to an average of 28.5 years of life lost per patient. Real-world data shows a 20-30% reduction in hospitalizations when using LAIs early, including following the first episode of psychosis.

"Traditional RCTs often underestimate the real-world advantage of LAIs because they artificially increase adherence in the oral control groups."

— Dr. Christoph Correll

Key Guideline Recommendations

fast_forward

Early Intervention

APA/AAPP guidelines recommend LAI initiation even after the first psychotic episode to protect neural tissue.

trending_down

Relapse Prevention

LAIs prevent the "compounding effects" of repeated relapses and subsequent functional decline.

track_changes

Monotherapy Goal

The goal should be full transition to LAI monotherapy, moving away from reactive "reserved for failure" models.

The "Wait & See" Myth

Electronic monitoring suggests oral adherence is only 40-50%, while clinicians often overestimate it at 74%. This discrepancy fuels the persistent underutilization of LAIs.

74%

Perceived Adherence

40%

Actual Adherence

Section 2

The Perception Gap: Shared Decision-Making

Reframing the Conversation

Shared decision-making (SDM) shifts the conversation from "Compliance" to achieving Patient-Centered Goals like stability, lifestyle convenience, and autonomy.

forum

Neutral Framing

Present LAIs as a choice, not a punishment for "failing" pills.

volunteer_activism

90% Acceptance Rate

With SDM training, patient acceptance jumps from 15% to 90%.

Patient Preferences: Reality vs. Perception

Clinician Misperception

"Patients will feel coerced if I suggest an injection. They prefer the control of taking a daily pill."

Patient Reality

"I value the freedom from the daily reminder of my illness. The injection gives me more autonomy."

77%

Preference

of patients surveyed report preferring LAIs over oral administration when benefits are collaboratively explained.

Section 3

Clinic Logistics & Transition Protocols

inventory_2 Inventory & Storage

check_circle Refrigeration requirements & temp logs
check_circle Stocking levels and ordering schedules
check_circle Disposal of sharps and biohazards

assignment_turned_in Administrative Support

check_circle Insurance & Prior Authorization support
check_circle Appointment scheduling (The "Injection Day" model)
check_circle Tracking and monitoring patient follow-ups

Transitioning Safely: The Critical Window

Up to 80% of patients experience medication discrepancies upon hospital discharge. Bridging the transition from inpatient to community care is vital.

Protocol 1

Oral Overlap & Loading

Each LAI has a specific overlap period (0 to 21 days). Maintenance doses must align with pharmacokinetic steady-state goals.

Avoid

The Polypharmacy Paradox

Indefinite maintenance of oral antipsychotics (OAs) after LAI steady-state increases rehospitalization risk by 49%.

Section 4

Knowledge Check

quiz Final Review

Core Curriculum

Test your understanding of early LAI guideline recommendations before moving to the simulation.

1. Which patient population do current guidelines explicitly recommend for early LAI initiation?

Virtual Injection Trainer

Practice identifying landmarks and administering gluteal/Ventrogluteal/deltoid injections.

Select an Injection Site to Begin

touch_app

Choose an injection site on the left